# Adenovirus (RGDCRAdCOX2F)

> **NCT06693986** · PHASE1 · RECRUITING · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 18 (estimated)

## Conditions studied

- Adenocarcinoma of Pancreas

## Interventions

- **BIOLOGICAL:** Replicative Adenovirus Vector (RGDCRAdCOX2F)

## Key facts

- **NCT ID:** NCT06693986
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-27
- **Primary completion:** 2028-10-15
- **Final completion:** 2029-10-15
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693986, "Adenovirus (RGDCRAdCOX2F)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06693986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*